Emerging data suggest Retatrutide , a dual agonist targeting both incretin and another hormone, could provide a notable step forward for weight treatment. Early human trials have shown considerable https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide